|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
The enzyme involved appears to
be a deoxyribonuclease which suggests it may have a critical role in the
pathway of apoptosis. Enzyme
inhibitors may therefore prevent DNA digestion as occurs in apoptosis or
prevent cell death. Furthermore,
knowledge of the cleavage site of this protein permits development of
specific substrates that can be used to investigate factors that regulate the
cleavage during apoptosis. Cloning and characterization
of the gene and protein also makes possible evaluation of this
deoxyribonuclease, or recombinant derivatives, as therapeutics. The ability of the isolated, purified
enzyme to digest DNA renders it potentially useful in conditions such as
Cystic Fibrosis wherein the accumulation of DNA in the lungs leads to extreme
discomfort and even suffocation. This
technology is claimed in the issued United States Patent No. 6,184,034. We are seeking an industrial partner to
further refine and market this technology. (Ref: J40) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
11 Rope Ferry Road #6210 |
||||
|
Hanover, NH 03755-1404 |
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|